244 related articles for article (PubMed ID: 25876268)
1. Murine infection models for the investigation of Campylobacter jejuni--host interactions and pathogenicity.
Heimesaat MM; Bereswill S
Berl Munch Tierarztl Wochenschr; 2015; 128(3-4):98-103. PubMed ID: 25876268
[TBL] [Abstract][Full Text] [Related]
2. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(5):e35988. PubMed ID: 22563475
[TBL] [Abstract][Full Text] [Related]
3. Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.
Mousavi S; Bereswill S; Heimesaat MM
Curr Top Microbiol Immunol; 2021; 431():233-263. PubMed ID: 33620654
[TBL] [Abstract][Full Text] [Related]
4. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.
Bereswill S; Fischer A; Plickert R; Haag LM; Otto B; Kühl AA; Dasti JI; Zautner AE; Muñoz M; Loddenkemper C; Gross U; Göbel UB; Heimesaat MM
PLoS One; 2011; 6(6):e20953. PubMed ID: 21698299
[TBL] [Abstract][Full Text] [Related]
5. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
6. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in
Heimesaat MM; Mrazek K; Bereswill S
Front Immunol; 2019; 10():2272. PubMed ID: 31616437
[TBL] [Abstract][Full Text] [Related]
7. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms.
Dasti JI; Tareen AM; Lugert R; Zautner AE; Gross U
Int J Med Microbiol; 2010 Apr; 300(4):205-11. PubMed ID: 19665925
[TBL] [Abstract][Full Text] [Related]
8. Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S
Front Cell Infect Microbiol; 2017; 7():322. PubMed ID: 28752081
[TBL] [Abstract][Full Text] [Related]
9. The second century of Campylobacter research: recent advances, new opportunities and old problems.
Dorrell N; Wren BW
Curr Opin Infect Dis; 2007 Oct; 20(5):514-8. PubMed ID: 17762786
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter jejuni: components for adherence to and invasion of eukaryotic cells.
Lugert R; Gross U; Zautner AE
Berl Munch Tierarztl Wochenschr; 2015; 128(3-4):90-7. PubMed ID: 25876267
[TBL] [Abstract][Full Text] [Related]
11. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.
Heimesaat MM; Alutis M; Grundmann U; Fischer A; Tegtmeyer N; Böhm M; Kühl AA; Göbel UB; Backert S; Bereswill S
Front Cell Infect Microbiol; 2014; 4():77. PubMed ID: 24959425
[TBL] [Abstract][Full Text] [Related]
12. A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection.
Watson RO; Novik V; Hofreuter D; Lara-Tejero M; Galán JE
Infect Immun; 2007 Apr; 75(4):1994-2003. PubMed ID: 17194808
[TBL] [Abstract][Full Text] [Related]
13. Experimental campylobacter infection and diarrhoea in immunodeficient mice.
Hodgson AE; McBride BW; Hudson MJ; Hall G; Leach SA
J Med Microbiol; 1998 Sep; 47(9):799-809. PubMed ID: 9736162
[TBL] [Abstract][Full Text] [Related]
14. Peptidase PepP is a novel virulence factor of
Heimesaat MM; Schmidt AM; Mousavi S; Escher U; Tegtmeyer N; Wessler S; Gadermaier G; Briza P; Hofreuter D; Bereswill S; Backert S
Gut Microbes; 2020 Nov; 12(1):1770017. PubMed ID: 32584649
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice.
Bereswill S; Alutis ME; Grundmann U; Fischer A; Göbel UB; Heimesaat MM
PLoS One; 2016; 11(6):e0158020. PubMed ID: 27322540
[TBL] [Abstract][Full Text] [Related]
16. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis.
Masanta WO; Heimesaat MM; Bereswill S; Tareen AM; Lugert R; Groß U; Zautner AE
Clin Dev Immunol; 2013; 2013():526860. PubMed ID: 24324507
[TBL] [Abstract][Full Text] [Related]
17. In vivo modulation of Campylobacter jejuni virulence in response to environmental stress.
Klančnik A; Vučković D; Plankl M; Abram M; Smole Možina S
Foodborne Pathog Dis; 2013 Jun; 10(6):566-72. PubMed ID: 23638846
[TBL] [Abstract][Full Text] [Related]
18. Glycoconjugates play a key role in Campylobacter jejuni Infection: interactions between host and pathogen.
Day CJ; Semchenko EA; Korolik V
Front Cell Infect Microbiol; 2012; 2():9. PubMed ID: 22919601
[TBL] [Abstract][Full Text] [Related]
19. The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice.
O'Loughlin JL; Samuelson DR; Braundmeier-Fleming AG; White BA; Haldorson GJ; Stone JB; Lessmann JJ; Eucker TP; Konkel ME
Appl Environ Microbiol; 2015 Jul; 81(14):4642-50. PubMed ID: 25934624
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
